Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 3,779 | 1,408 | 1,444 | 2,088 | 1,246 |
| Cost of Goods | 38 | 44 | 98 | 256 | 169 |
| Gross Profit | 3,741 | 1,364 | 1,346 | 1,832 | 1,077 |
| Operating Expenses | 7,619 | 7,275 | 8,105 | 8,450 | 7,951 |
| Operating Income | -3,840 | -5,867 | -6,661 | -6,362 | -6,705 |
| Other Income | 839 | 94 | 103 | 1,648 | -453 |
| Pre-tax Income | -3,001 | -5,773 | -6,558 | -4,714 | -7,158 |
| Net Income Continuous | -3,001 | -5,773 | -6,558 | -4,714 | -7,158 |
| Minority Interests | 33 | -13 | -16 | 61 | -48 |
| Net Income | $-3,034 | $-5,760 | $-6,542 | $-4,775 | $-7,110 |
| EPS Basic Total Ops | -0.02 | -0.03 | -0.04 | -0.02 | -0.04 |
| EPS Basic Continuous Ops | -0.02 | -0.03 | -0.04 | -0.03 | -0.04 |
| EPS Diluted Total Ops | -0.02 | -0.03 | -0.04 | -0.02 | -0.04 |
| EPS Diluted Continuous Ops | -0.02 | -0.03 | -0.04 | -0.03 | -0.04 |
| EPS Diluted Before Non-Recurring Items | -0.02 | -0.03 | -0.04 | N/A | N/A |
| EBITDA(a) | $-3,710 | $-5,745 | $-6,486 | $-6,182 | $-6,524 |